{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:43:33Z","timestamp":1773290613691,"version":"3.50.1"},"reference-count":97,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2001,9,1]],"date-time":"2001-09-01T00:00:00Z","timestamp":999302400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Heart Fail Rev"],"published-print":{"date-parts":[[2001,9]]},"DOI":"10.1023\/a:1011414307636","type":"journal-article","created":{"date-parts":[[2002,12,23]],"date-time":"2002-12-23T10:16:33Z","timestamp":1040638593000},"page":"227-240","source":"Crossref","is-referenced-by-count":20,"title":["The Challenge of Rejection and Cardiac Allograft Vasculopathy"],"prefix":"10.1007","volume":"6","author":[{"given":"William G.","family":"Cotts","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maryl R.","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","reference":[{"key":"337177_CR1","first-page":"323","volume":"9","author":"JM Kriett","year":"1990","unstructured":"Kriett JM, Kay MP. The registry of the international society for heart transplantation: seventh office report. J Heart Transplant 1990;9:323-330","journal-title":"J Heart Transplant"},{"key":"337177_CR2","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/S0735-1097(98)90045-6","volume":"11","author":"JK Kirklin","year":"1988","unstructured":"Kirklin JK, Naftel DC, McGiffin DC, McVay RF, Blackstone EH, Karp RB. Analysis of morbid events and risk factors for death after cardiac transplantation. J Am Coll Cardiol 1988;11:917\u2013924.","journal-title":"J Am Coll Cardiol"},{"key":"337177_CR3","first-page":"894","volume":"10","author":"KR Reid","year":"1991","unstructured":"Reid KR, Menkis AH, Novick RJ, et al. Reduced incidence of severe infection after heart transplantation with low-intensity immunosuppression. J Heart Lung Transplant 1991;10:894\u2013900.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR4","first-page":"312","volume":"4","author":"J Brumbaugh","year":"1985","unstructured":"Brumbaugh J, Baldwin JC, Stinson EB. Quantitative analysis of immunosuppression in cyclosporine-treated heart transplant patients with lymphoma. J Heart Transplant 1985;4:312\u2013314.","journal-title":"J Heart Transplant"},{"key":"337177_CR5","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1056\/NEJM199012203232502","volume":"323","author":"LJ Swinnen","year":"1990","unstructured":"Swinnen LJ, Costanzo-Nordin MR, Fisher SG, et al. Increased incidence of lymphoproliferative disorder after immunosuppression with the monoclonal antibody OKT3 in cardiac-transplant recipients. N Eng J Med 1990;323:1723\u20131728.","journal-title":"N Eng J Med"},{"key":"337177_CR6","first-page":"283","volume":"313","author":"PF Halloran","year":"1997","unstructured":"Halloran PF. Immunosuppressive agents in clinical trials in transplantation. Am J Med Sci 1997;313:283\u2013288.","journal-title":"Am J Med Sci"},{"key":"337177_CR7","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.1997.03550220199025","volume":"278","author":"AM VanBuskirk","year":"1997","unstructured":"VanBuskirk AM, Pidwell DJ, Adams PW, Orosz CG. Transplantation immunology. JAMA 1997;278:1993\u20131999.","journal-title":"JAMA"},{"key":"337177_CR8","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1096\/fasebj.8.14.7958617","volume":"8","author":"CY Lu","year":"1994","unstructured":"Lu CY, Khair-el-Din TA, Dawidson IA, et al. Xeno-transplantation. FASEB J 1994;8:1122\u20131130.","journal-title":"FASEB J"},{"key":"337177_CR9","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/0162-3109(92)90020-D","volume":"24","author":"AP Dalmasso","year":"1992","unstructured":"Dalmasso AP. The complement system in xeno-transplantation. Immunopharmacology 1992;24:149\u2013160.","journal-title":"Immunopharmacology"},{"key":"337177_CR10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1097\/00007890-199209000-00001","volume":"54","author":"JC Scornik","year":"1992","unstructured":"Scornik JC, Brunson ME, Howard RJ, Pfaff WW. Alloimmunization, memory, and the interpretation of crossmatch results for renal transplantation recipient. Transplantation 1992;54:389\u2013394.","journal-title":"Transplantation"},{"key":"337177_CR11","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/0198-8859(89)90003-7","volume":"26","author":"WE Braun","year":"1989","unstructured":"Braun WE. Laboratory and clinical management of the highly sensitized organ transplant recipient. Hum Immunol 1989;26:245\u2013260.","journal-title":"Hum Immunol"},{"key":"337177_CR12","first-page":"1123","volume-title":"Manual of Clinical Laboratory Immunology","author":"P Beatty","year":"1997","unstructured":"Beatty P. Histocompatibility assessment in bone marrow transplantation. In: Rose N, Macario EC, Folds JD, Lane HC, Nakamura RM, eds. Manual of Clinical Laboratory Immunology, Washington, DC: American Society of Microbiology, 1997:1123\u20131131."},{"key":"337177_CR13","first-page":"127","volume":"6","author":"A Herskowitz","year":"1987","unstructured":"Herskowitz A, Soule LM, Ueda K, et al. Arteriolar vasculitis on endomyocardial biopsy: a histologic predictor of poor outcome in cyclosporin treated heart transplant recipients. J Heart Transplant 1987;6:127\u2013136.","journal-title":"J Heart Transplant"},{"key":"337177_CR14","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1016\/0002-9149(87)90869-1","volume":"59","author":"SH Smith","year":"1987","unstructured":"Smith SH, Kirklin JK, Geer JC, et al. Arteritis and cardiac rejection after transplantation. Am J Cardiol 1987;59:1171\u20131173.","journal-title":"Am J Cardiol"},{"key":"337177_CR15","first-page":"191","volume":"7","author":"RL Yowell","year":"1988","unstructured":"Yowell RL, Hammond EH, Bristow MR, et al. Acute vascular rejection involving the major coronary arteries of a cardiac allograft. J Heart Transplant 1988;7:191\u2013197.","journal-title":"J Heart Transplant"},{"key":"337177_CR16","first-page":"430","volume":"8","author":"EH Hammond","year":"1989","unstructured":"Hammond EH, Yowell RL, Nunoda S, et al. Vascular (humoral) rejection in heart transplantation: pathologic observation and clinical implications. J Heart Transplant 1989;8:430\u2013443.","journal-title":"J Heart Transplant"},{"key":"337177_CR17","first-page":"813","volume":"16","author":"RM Mills","year":"1997","unstructured":"Mills RM, Naftel DC, Kirklin JK, et al. Heart transplant rejection with hemodynamic compromise: A multiinstitutional study of the role of endomyocardial cellular infiltrate. J Heart Lung Transplant 1997;16:813\u2013821.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR18","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0733-8651(18)30385-0","volume":"8","author":"SL Woodley","year":"1990","unstructured":"Woodley SL, Benlund DG, O'Connell JB, Bristow MR. Immunosuppression following cardiac transplantation. Cardiol Clin 1990;8:83\u201396.","journal-title":"Cardiol Clin"},{"key":"337177_CR19","first-page":"587","volume":"9","author":"ME Billingham","year":"1990","unstructured":"Billingham ME, Cary NRB, Hammond ME, et al. A working formulation for the standardization of nomenclature in the diagnosis of heart and lung rejection: heart rejection study group. J Heart Lung Transplant 1990;9:587\u2013593.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR20","first-page":"1","volume":"13","author":"HA McAllister","year":"1986","unstructured":"McAllister HA, Schnee MJM, Radovancevic B, Frazier OH. A system for grading cardiac allograft rejection. Tex Heart Inst J 1986;13:1\u20133.","journal-title":"Tex Heart Inst J"},{"key":"337177_CR21","first-page":"525","volume":"4","author":"W Paulsen","year":"1985","unstructured":"Paulsen W, Magid N, Sagar K, et al. Left ventricular function of heart allografts during acute rejection: an echocardiographic assessment. Heart Transplant 1985;4:525\u2013529.","journal-title":"Heart Transplant"},{"key":"337177_CR22","first-page":"430","volume":"7","author":"T Forster","year":"1988","unstructured":"Forster T, McGhie J, Rijsterborgh H, van de Borden S, Laird-Meeter K, Balk A, Essed C, Roelandt J. Can we assess the changes of ventricular filling resulting from acute allograft rejection with doppler echocardiography? J Heart Transplant 1988;7:430\u2013434.","journal-title":"J Heart Transplant"},{"issue":"supplV","key":"337177_CR23","first-page":"V86","volume":"76","author":"HA Valantine","year":"1987","unstructured":"Valantine HA, Fowler MB, Hunt SA, et al. Changes in doppler echocardiographic indexes of left ventricular function as potential markers of acute cardiac rejection. Circulation 1987;76(suppl V):V86-V92.","journal-title":"Circulation"},{"key":"337177_CR24","first-page":"S221","volume":"11","author":"BM Kemkes","year":"1992","unstructured":"Kemkes BM, Schutz A, Engelhardt M, Brandl U, Breuer M. Noninvasive methods of rejection diagnosis after heart transplantation. J Heart Lung Transplant 1992; 11:S221-S231.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR25","first-page":"355","volume":"12","author":"JA Kobashigawa","year":"1993","unstructured":"Kobashigawa JA, Kirklin JK, Naftel DC, et al. Pretransplantation risk factors for acute rejection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1993;12:355\u2013366.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR26","first-page":"583","volume":"13","author":"J Jarcho","year":"1994","unstructured":"Jarcho J, Naftel C, Shroyer TW, et al. Influence of HLA mismatch on rejection after heart transplantation: a multiinstitutional study. J Heart Lung Transplant 1994;13:583\u2013596.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR27","first-page":"921","volume":"10","author":"J Lavee","year":"1991","unstructured":"Lavee J, Kormos RL, Duquesnoy RJ, et al. Influence of panel-reactive antibody and lymphocytotoxic cross-match on survival after heart transplantation. J Heart Lung Transplant 1991;10:921\u2013930.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR28","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S1053-2498(99)00022-4","volume":"18","author":"BA Pisani","year":"1999","unstructured":"Pisani BA, Mullen M, Malinowska K, et al. Plasmapheresis with intravenous immunoglobulin G is effective in patients with elevated panel reactive antibody prior to cardiac transplant. J Heart Lung Transplant 1999;18:701\u2013706.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR29","first-page":"801","volume":"16","author":"MR Johnson","year":"1997","unstructured":"Johnson MR, Naftel DC, Hobbs RE, et al. The incremental risk of female sex in heart transplantation: a multiinstitutional study of peripartum cardiomyopathy and pregnancy. J Heart Lung Transplant 1997;16:801\u2013812.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR30","first-page":"409","volume":"14","author":"SH Kubo","year":"1995","unstructured":"Kubo SH, Naftel DC, Mills RM, et al. Risk factors for late recurrent rejection after heart transplantation: a multiinstitutional, multivariable analysis. J Heart Lung Transplant 1995;14:409\u2013418.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1097\/00007890-198610000-00006","volume":"42","author":"E von Willebran","year":"1986","unstructured":"von Willebran E, Petterson E, Atonen J, et al. CMV infection, class II antigen expression, and human kidney allograft rejection. Transplantation 1986;42:364\u2013367.","journal-title":"Transplantation"},{"key":"337177_CR32","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/00007890-198402000-00004","volume":"37","author":"A van Es","year":"1984","unstructured":"van Es A, Baldwin WM, Olijans PJ, Tanke HJ, Ploem JS, van Es LA. Expression of HLA-DR on T lymphocytes following renal transplantation, and association with graft rejection episodes and cytomegalovirus infection. Transplant 1984;37:65\u201369.","journal-title":"Transplant"},{"key":"337177_CR33","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/00007890-199306000-00029","volume":"55","author":"WT van Dorp","year":"1993","unstructured":"van Dorp WT, van Wieringen PAM, Marselis-Jonges E, et al. Cytomegalovirus directly enhances MHC Class I and intercellular adhesion molecule-1 expression on cultured proximal tubular epithelial cells. Transplantation 1993;55:1367\u20131371.","journal-title":"Transplantation"},{"key":"337177_CR34","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/0167-5699(85)90010-6","volume":"6","author":"JSH Gaston","year":"1985","unstructured":"Gaston JSH, Waer M. Virus-specific MHC restricted T-lymphocytes may initiate allograft rejection. Immunol Today 1985;6:237\u2013241.","journal-title":"Immunol Today"},{"issue":"supplIV","key":"337177_CR35","first-page":"IV276","volume":"82","author":"MT Olivari","year":"1990","unstructured":"Olivari MT, Kubo SH, Braunlin EA, Bolman RM, Ring WS. Five-year experience with triple-drug immunosuppressive therapy in cardiac transplant. Circulation 1990;82(suppl IV):IV276-IV280.","journal-title":"Circulation"},{"key":"337177_CR36","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1097\/00007890-198904000-00007","volume":"47","author":"DG Renlund","year":"1989","unstructured":"Renlund DG, O'Connell JB, Gilbert EM, et al. A prospective comparison of murine monoclonal CD-3 (OKT3) antibody-based and equine antithymocyte globulin-based rejection prophylaxis in cardiac transplantation. Decreased rejection and less corticosteroid use with OKT3. Transplantation 1989;47:599\u2013605.","journal-title":"Transplantation"},{"issue":"supplIV","key":"337177_CR37","first-page":"IV291","volume":"82","author":"ML Barr","year":"1990","unstructured":"Barr ML, Sanchez JA, Seche LA, Schulman LL, Smith CR, Rose EA. Anti-CD3 monoclonal antibody induction therapy. Immunological equivalency with triple-drug therapy in heart transplantation. Circulation 1990;82(suppl IV):IV291-IV294.","journal-title":"Circulation"},{"key":"337177_CR38","first-page":"901","volume":"10","author":"M Prieto","year":"1991","unstructured":"Prieto M, Lake KD, Pritzker MR, et al. OKT3 induction and steroid-free maintenance immunosuppression for treatment of high-risk heart transplant recipients. J Heart Lung Transplant 1991;10:901\u2013911.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR39","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/0002-9149(94)90368-9","volume":"74","author":"MR Johnson","year":"1994","unstructured":"Johnson MR, Mullen GM, O'Sullivan EJ, et al. Risk\/benefit ratio of perioperative OKT3 in cardiac transplantation. Am J Cardiol 1994;74:261\u2013266.","journal-title":"Am J Cardiol"},{"key":"337177_CR40","first-page":"205","volume":"12","author":"JA Kobashigawa","year":"1993","unstructured":"Kobashigawa JA, Stevenson LW, Brownfield E, et al. Does short-course induction with OKT3 improve outcome after heart transplantation? A randomized trial. J Heart Lung Transplant 1993;12:205\u2013208.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR41","first-page":"159","volume":"8","author":"JD Hosenpud","year":"1989","unstructured":"Hosenpud JD, Douglas JN, Pantely GA, et al. OKT3-induced hypotension in heart allograft recipients treated for steroid-resistent rejection. J Heart Transplant 1989;8:159\u2013166.","journal-title":"J Heart Transplant"},{"key":"337177_CR42","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S0966-3274(96)80029-3","volume":"4","author":"F Pazderka","year":"1996","unstructured":"Pazderka F, Enns J, Batiuk TD, Halloran PF. The functional consequences of partial calcineurin inhibition in human peripheral blood mononuclear leucocytes. Transpl Immunol 1996;4:23\u201331.","journal-title":"Transpl Immunol"},{"key":"337177_CR43","first-page":"787","volume":"16","author":"M White","year":"1997","unstructured":"White M, Pelletier GB, Tan A, Jesina C, Carrier M. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients. J Heart Lung Transplant 1997;16:787\u2013794.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR44","first-page":"663","volume":"68","author":"HJ Eisen","year":"1999","unstructured":"Eisen HJ, Hobbs RE, Davis SF, et al. Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine-results at six months after transplantation 1999;68:663\u2013671.","journal-title":"Safety, tolerability and efficacy of cyclosporine microemulsion in heart transplant recipients: a randomized, multicenter, double-blind comparison with the oil based formulation of cyclosporine-results at six months after transplantation"},{"key":"337177_CR45","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S1053-2498(98)00060-6","volume":"18","author":"DO Taylor","year":"1999","unstructured":"Taylor DO, Barr ML, Radovancevic B, et al. A randomized, multicenter comparison of tacrolimus and cyclosporine immunosuppressive regimens in cardiac transplantation: decreased hyperlipidemia and hypertension with tacrolimus. J Heart Lung Transplant 1999;18:336\u2013345.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR46","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/0092-8674(95)90439-5","volume":"82","author":"JP Griffith","year":"1995","unstructured":"Griffith JP, Kim JL, Kim EE, et al. X-ray structure of calcineurin inhibited by the immunophilin-immunosuppressant FKBP 12-FK506 complex. Cell 1995;82:507\u2013522.","journal-title":"Cell"},{"key":"337177_CR47","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1038\/378641a0","volume":"378","author":"CR Kissinger","year":"1995","unstructured":"Kissinger CR, Parge HE, Knighton DR, et al. Crystal structure of human calcineurin and the human FKBP12-FK506-calcineurin complex. Nature 1995;378:641\u2013644.","journal-title":"Nature"},{"key":"337177_CR48","first-page":"782","volume":"17","author":"BM Meiser","year":"1998","unstructured":"Meiser BM, Fuchs UA, Schmidt D, et al. Single-center randomized trial comparing tacrolimus (FK506) and cyclosporine in the prevention of acute myocardial rejection. J Heart Lung Transplant 1998;17:782\u2013788.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR49","first-page":"1039","volume":"15","author":"DO Taylor","year":"1996","unstructured":"Taylor DO, Bristow MR, O'Connell JB, et al. Improved long-term survival after heart transplantation predicted by successful early withdrawal from maintenance corticosteroid therapy. J Heart Lung Transplant 1996;15:1039\u20131046.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR50","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1097\/00007890-199808270-00016","volume":"66","author":"J Kobashigawa","year":"1998","unstructured":"Kobashigawa J, Miller L, Renlund D, et al. A randomized active-controlled trial of mycophenolate mofetil in heart transplant recipients. Transplantation 1998;66:507\u2013515.","journal-title":"Transplantation"},{"key":"337177_CR51","first-page":"53","volume":"18","author":"A Keogh","year":"1999","unstructured":"Keogh A, Bourge R, Costanzo M, et al. Three-year results of the double-blind randomized multicenter trial of mycophenolate mofetil in heart transplant patients. J Heart Lung Transplant 1999;18:53 (Abstract).","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR52","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1111\/j.1525-1594.1994.tb03340.x","volume":"18","author":"JT Wolfe","year":"1994","unstructured":"Wolfe JT, Lessin SR, Singh AH, Rook AH. Review of immunomodulation by photopheresis: treatment of cutaneous T-cell lymphoma, autoimmune disease, and allograft rejection. Artif Organs 1994;18:888\u2013897.","journal-title":"Artif Organs"},{"key":"337177_CR53","doi-asserted-by":"crossref","first-page":"1744","DOI":"10.1056\/NEJM199812103392404","volume":"339","author":"ML Barr","year":"1998","unstructured":"Barr ML, Meiser BM, Eise HJ, et al. Photopheresis for the prevention of rejection in cardiac transplantation. N Engl J Med 1998;339:1744\u20131751.","journal-title":"N Engl J Med"},{"key":"337177_CR54","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/jcp.1041370116","volume":"137","author":"JW Doyle","year":"1988","unstructured":"Doyle JW, Kandutsch AA. Requirement for mevalonate in cycling cells: quantitative and temporal aspects. J Cell Physiol 1988;137:133\u2013140.","journal-title":"J Cell Physiol"},{"key":"337177_CR55","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/0021-9150(91)90116-K","volume":"90","author":"J Kruezer","year":"1991","unstructured":"Kruezer J, Bader J, Jahn L, Hautmann M, Kubler W, Von Hodenberg E. Chemotaxis of the monocyte cell line U937: dependence on cholesterol and early mevalonate pathway products. Atherosclerosis 1991;90:203\u2013209.","journal-title":"Atherosclerosis"},{"key":"337177_CR56","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1002\/jcp.1041390314","volume":"139","author":"JL Cutts","year":"1989","unstructured":"Cutts JL, Scallen TJ, Watson J, Bankhurst AD. Role of mevalonic acid in the regulation of natural killer cell cytotoxicity. J Cell Physiol 1989;139:550\u2013557.","journal-title":"J Cell Physiol"},{"key":"337177_CR57","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1002\/jcp.1041450208","volume":"145","author":"JL Cutts","year":"1990","unstructured":"Cutts JL, Bankhurst AD. Reversal of lovastatin-mediated inhibition of natural killer cell cytotoxicity by interleukin 2. J Cell Physiol 1990;145:244\u2013252.","journal-title":"J Cell Physiol"},{"key":"337177_CR58","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199509073331003","volume":"333","author":"JA Kobashigawa","year":"1995","unstructured":"Kobashigawa JA, Katnelson S, Laks H, Johnson JA, Yeatman L, et al. Effect of pravastatin on outcomes after cardiac transplantation. N Eng J Med 1995;333:621\u2013627.","journal-title":"N Eng J Med"},{"key":"337177_CR59","first-page":"269","volume-title":"Drugs of abuse, immunity and immunodeficiency. Vol. 288 of Advances in experimental medicine and biology","author":"J Linna","year":"1991","unstructured":"Linna J, Moke M, Chen HW. Isoprenoid formation and cell mediated immunological functions. In: Friedman H, Specter S, Klein TW, eds. Drugs of abuse, immunity and immunodeficiency. Vol. 288 of Advances in experimental medicine and biology. New York: Plenum Press, 1991:269\u2013278."},{"key":"337177_CR60","first-page":"1398","volume":"96","author":"K Wenke","year":"1997","unstructured":"Wenke K, Meiser B, Thiery J, Nagel D, von Scheidt W, et al. Simvastatin reduces graft vessel disease and mortality after heart transplantation. 1997;96:1398\u20131402.","journal-title":"Simvastatin reduces graft vessel disease and mortality after heart transplantation"},{"issue":"supplIII","key":"337177_CR61","first-page":"III47","volume":"78","author":"MR Costanzo","year":"1988","unstructured":"Costanzo MR, Grusk BB, Silver MA, et al. Reversal of recalcitrant cardiac allograft rejection with methotrexate. Circulation 1988;78(suppl III):III47-III57.","journal-title":"Circulation"},{"key":"337177_CR62","first-page":"A49","volume":"8","author":"SL Olsen","year":"1989","unstructured":"Olsen SL, O'Connell JB, Bristow BR, et al. Methotrexate (MTX) in the treatment of persistent cardiac allograft rejection. J Heart Transplant 1989;8:A49 (Abstract).","journal-title":"J Heart Transplant"},{"key":"337177_CR63","first-page":"739","volume":"11","author":"JD Hosenpud","year":"1992","unstructured":"Hosenpud JD, Hershberger RE, Ratkovec RM, et al. Methotrexate for the treatment of patients with multiple episodes of acute cardiac allograft rejection. J Heart Lung Transplant 1992;11:739\u2013745.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR64","first-page":"179","volume":"16","author":"HJ Ross","year":"1997","unstructured":"Ross HJ, Gullestad L, Pak J, Slauson S, Valantine HA, Hunt SA. Methotrexate or total lymphoid radiation for treatment of persistent or recurrent allograft cellular rejection: a comparative study. J Heart Lung Transplant 1997;16:179\u2013189.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR65","first-page":"A127","volume":"17","author":"RC Bourge","year":"1998","unstructured":"Bourge RC, Kirklin JK, McGiffin DC, et al. Total lymphoid irradiation after cardiac transplantation: is there a risk of late leukemia? J Heart Lung Transplant 1998;17:A127 (Abstract).","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR66","doi-asserted-by":"crossref","first-page":"A245","DOI":"10.1016\/S1053-2498(99)80252-6","volume":"18","author":"PA McGurl","year":"1999","unstructured":"McGurl PA, Platsoucas CD, Ricordi C, Slachta CA, et al. Efficacy of donor specific bone marrow in reducing frequency of rejection following heart transplantation. J Heart Lung Transplant 1999;18:A245 (Abstract).","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR67","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1056\/NEJM199801153380304","volume":"338","author":"F Vincenti","year":"1998","unstructured":"Vincenti F, Kirkman R, Light S, et al. Interleukin-2-receptor blockade with daclizumab to prevent acute rejection in renal transplantation. N Engl J Med 1998;338:161\u2013165.","journal-title":"N Engl J Med"},{"key":"337177_CR68","first-page":"541","volume":"12","author":"MP Kay","year":"1993","unstructured":"Kay MP. The Registry of the International Society for Heart and Lung Transplantation: tenth official report-1993. J Heart Lung Transplant 1993;12:541\u2013548.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR69","first-page":"9","volume":"11","author":"JD Hosenpud","year":"1992","unstructured":"Hosenpud JD, Shipley GD, Wagner CR. Cardiac allograft vasculopathy: current concepts, recent developments, and future directions. J Heart Lung Transplant 1992;11:9\u201323.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR70","first-page":"744","volume":"17","author":"MR Costanzo","year":"1998","unstructured":"Costanzo MR, Naftel DC, Pritzker MR, et al. Heart transplant coronary artery disease detected by coronary angiography: a multiinstitutional study of preoperative donor and recipient risk factors. J Heart Lung Transplant 1998;17:744\u2013753.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR71","first-page":"S215","volume":"14","author":"AC Yeung","year":"1995","unstructured":"Yeung AC, Davis SF, Hauptman PJ, Kobashigawa JA, Miller LW, et al. Incidence and progression of transplant coronary artery disease over 1 year: results of a multicenter trial with use of intravascular ultrasound. J Heart Lung Transplant 1995;14:S215-S220.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR72","first-page":"S104","volume":"11","author":"T Zerbe","year":"1992","unstructured":"Zerbe T, Uretski B, Kormos R, et al. Graft atherosclerosis: effects of cellular rejection and human lymphocyte antigen. J Heart Lung Transplant 1992;11:S104-S110.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR73","first-page":"317","volume-title":"Cardiovascular pathology","author":"G Baroldi","year":"1983","unstructured":"Baroldi G. Diseases of the coronary arteries. In: Silver, ed. Cardiovascular pathology. New York: Churchill Livingstone, 1983:317\u2013391."},{"key":"337177_CR74","first-page":"339","volume":"9","author":"AM Pucci","year":"1990","unstructured":"Pucci AM, Forbes RDC, Billingham ME. Pathologic features in long-term cardiac allografts. J Heart Transplant 1990;9:339\u2013345.","journal-title":"J Heart Transplant"},{"key":"337177_CR75","first-page":"S5","volume":"11","author":"P Libby","year":"1992","unstructured":"Libby P, Swanson SJ, Tanaka H, et al. Immunopathology of coronary arteriosclerosis in transplanted hearts. J Heart Lung Transplant 1992;11:S5-S6.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR76","first-page":"874","volume":"137","author":"RH Hruban","year":"1990","unstructured":"Hruban RH, Beschorner WE, Baumgartner WA, et al. Accelerated arteriosclerosis in heart transplant recipients is associated with a T-lymphocyte-mediated endothelialitis. Am J Pathol 1990;137:874\u2013882.","journal-title":"Am J Pathol"},{"key":"337177_CR77","first-page":"791","volume":"138","author":"RN Salomon","year":"1991","unstructured":"Salomon RN, Hughes CCW, Schoen FJ, Payne DD, Pober JS, Libby P. Human coronary transplantation-associated arteriosclerosis; evidence for a chronic immune reaction to activated graft endothelial cells. Am J Pathol 1991;138:791\u2013798.","journal-title":"Am J Pathol"},{"key":"337177_CR78","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/1050-1738(91)90041-C","volume":"1","author":"FJ Schoen","year":"1991","unstructured":"Schoen FJ, Libby P. Cardiac transplant graft arteriosclerosis. Trends Cardiovasc Med 1991;1:216\u2013223.","journal-title":"Trends Cardiovasc Med"},{"key":"337177_CR79","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/00001573-199503000-00014","volume":"10","author":"RJ Duquesnoy","year":"1995","unstructured":"Duquesnoy RJ, Demetris AJ. Immunopathology of cardiac transplant rejection. Curr Opin Cardiol 1995;10:193\u2013206.","journal-title":"Curr Opin Cardiol"},{"key":"337177_CR80","first-page":"S173","volume":"14","author":"PJ Hauptman","year":"1995","unstructured":"Hauptman PJ, Nakagawa T, Tanaka H, Libby P. Acute rejection: culprit or coincidence in the pathogenesis of cardiac graft vascular disease? J Heart Lung Transplant 1995;14:S173-S180.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR81","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1097\/00007890-199102000-00050","volume":"51","author":"DM Briscoe","year":"1991","unstructured":"Briscoe DM, Schoen FJ, Payne DD, Pober JS, Libby P. Induced expression of endothelial-leukocyte adhesion molecules in human cardiac allografts. Transplantation 1991;51:537\u2013539.","journal-title":"Transplantation"},{"key":"337177_CR82","first-page":"938","volume":"144","author":"H Tanaka","year":"1994","unstructured":"Tanaka H, Sukhova G, Swanson S, Cybulsky M, Schoen F, Libby P. Endothelial and smooth muscle cells express leukocyte adhesion molecules heterogeneously during acute rejection of rabbit cardiac allografts. Am J Pathol 1994;144:938\u2013951.","journal-title":"Am J Pathol"},{"issue":"suppl","key":"337177_CR83","first-page":"III111","volume":"80","author":"MT Olivari","year":"1989","unstructured":"Olivari MT, Homans DC, Wilson RF, Kubo SH, Ring WS. Coronary artery disease in cardiac transplant patients receiving triple-drug immumnosuppressive therapy. Circulation 1989;80(suppl):III111-III115.","journal-title":"Circulation"},{"key":"337177_CR84","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/1010-7940(90)90207-G","volume":"4","author":"B Radovancevic","year":"1990","unstructured":"Radovancevic B, Poindexter S, Birovljev S, et al. Risk factors for development of accelerated coronary artery disease in cardiac transplant recipients. Eur J Cardiothorac Surg 1990;4:309\u2013312.","journal-title":"Eur J Cardiothorac Surg"},{"key":"337177_CR85","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1161\/01.CIR.76.4.827","volume":"76","author":"BF Uretsky","year":"1987","unstructured":"Uretsky BF, Murali S, Reddy PS, et al. Development of coronary artery disease in cardiac transplant patients receiving immunosuppresive therapy with cyclosporine and prednisone. Circulation 1987;76:827\u2013834.","journal-title":"Circulation"},{"key":"337177_CR86","first-page":"1975","volume":"91","author":"GL Winters","year":"1990","unstructured":"Winters GL, Kendall TJ, Radio SJ, et al. Posttransplant obesity and hyperlipidemia: major predictors of severity of coronary arteriopathy in failed human heart allografts. J Heart Transplant 1990;91:1975\u20131980.","journal-title":"J Heart Transplant"},{"key":"337177_CR87","first-page":"S124","volume":"11","author":"MJ Johnson","year":"1992","unstructured":"Johnson MJ. Transplant coronary disease: nonimmunologic riskfactors. J Heart Lung Transplant 1992;11:S124-S132.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR88","first-page":"S238","volume":"14","author":"PJ Hauptman","year":"1995","unstructured":"Hauptman PJ, Davis SF, Miller L, Yeung AC on behalf of the multicenter intravascular ultrasound transplant study group. The role of nonimmune risk factors in the development and progression of graft arteriosclerosis: preliminary insights from a multicenter intravascular ultrasound study. 1995;14:S238-S242.","journal-title":"The role of nonimmune risk factors in the development and progression of graft arteriosclerosis: preliminary insights from a multicenter intravascular ultrasound study"},{"key":"337177_CR89","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/0002-8703(94)90011-6","volume":"128","author":"MS Kemma","year":"1994","unstructured":"Kemma MS, Valantine HA, Hunt SA, Schroeder JS, Chen Y-D, Reaven GM. Metabolic risk factors for atherosclerosis in heart transplant recipients. Am Heart J 1994;128:68\u201372.","journal-title":"Am Heart J"},{"key":"337177_CR90","first-page":"S234","volume":"14","author":"HA Valantine","year":"1995","unstructured":"Valantine HA. Role of lipids in allograft vascular disease: a multicenter study of intimal thickening detected by intravascular ultrasound. J Heart Lung Transplant 1995;14:S234-S237.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR91","first-page":"1024","volume":"13","author":"KO Akosah","year":"1994","unstructured":"Akosah KO, Mohanty PK, Funai JT, Jesse RL, Minisi AJ, Crandall CW, Kirchberg PA, Guerraty A, Salter D. Noninvasive detection of transplant coronary artery disease by dobutamine stress echocardiography. J Heart Lung Transplant 1994;13:1024\u20131038.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR92","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1056\/NEJM199301213280303","volume":"328","author":"JS Schroeder","year":"1993","unstructured":"Schroeder JS, Gao S-Z, Alderman EL, Hunt SA, Johnstone I, et al. A preliminary study of diltiazem in the prevention of coronary artery disease in heart-transplant recipients. N Engl J Med 1993;328:164\u2013170.","journal-title":"N Engl J Med"},{"key":"337177_CR93","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1161\/01.CIR.86.2.458","volume":"86","author":"AA Halle III","year":"1992","unstructured":"Halle III AA, Wilson RF, Massin EK, et al. Coronary angioplasty in cardiac transplant patients: results of a multicenter study. Circulation 1992;86:458\u2013462.","journal-title":"Circulation"},{"key":"337177_CR94","first-page":"1936","volume":"3","author":"W von Scheidt","year":"1995","unstructured":"von Scheidt W, Uberfuhr P, Reichart B, Steinbeck G. The role of PTCA in the management of focal critical lesions in transplant coronary artery disease. Transplant Proc 1995;3:1936\u20131938.","journal-title":"Transplant Proc"},{"key":"337177_CR95","first-page":"819","volume":"12","author":"SP Jain","year":"1993","unstructured":"Jain SP, Ventura HO, Ramee SR, Collins TJ, Isner JM, White CJ. Directional coronary atherectomy in heart transplant recipients. J Heart Lung Transplant 1993;12:819\u2013823.","journal-title":"J Heart Lung Transplant"},{"key":"337177_CR96","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/0003-4975(90)90364-C","volume":"49","author":"JG Copeland","year":"1990","unstructured":"Copeland JG, Butman SM, Sehti G. Successful coronary artery bypass grafting for high-risk left main coronary artery atherosclerosis after cardiac transplantation. Ann Thorac Surg 1990;49:106\u2013110.","journal-title":"Ann Thorac Surg"},{"key":"337177_CR97","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/0735-1097(95)00124-I","volume":"26","author":"AA Halle III","year":"1995","unstructured":"Halle III AA, DiSciascio G, Massin EK, et al. Coronary angioplasty, atherectomy and bypass surgery in cardiac transplant recipients. J Am Coll Cardiol 1995;26:120\u2013128.","journal-title":"J Am Coll Cardiol"}],"container-title":["Heart Failure Reviews"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011414307636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1023\/A:1011414307636\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1023\/A:1011414307636.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T10:34:02Z","timestamp":1747996442000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1023\/A:1011414307636"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2001,9]]},"references-count":97,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2001,9]]}},"alternative-id":["337177"],"URL":"https:\/\/doi.org\/10.1023\/a:1011414307636","relation":{},"ISSN":["1382-4147","1573-7322"],"issn-type":[{"value":"1382-4147","type":"print"},{"value":"1573-7322","type":"electronic"}],"subject":[],"published":{"date-parts":[[2001,9]]}}}